Novogene Technology Receives $75,000,000 Series B Funding Round

  • Feed Type
  • Date
    12/1/2016
  • Company Name
    Novogene Technology
  • Mailing Address
    823 Anchorage Place Chula Vista, CA 91914 USA
  • Company Description
    Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and one of the largest sequencing capacities in the world.
  • Website
    http://www.novogene.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $75,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Series B financing will support strategic growth in Novogene’s global NGS service market and in clinical sequencing R&D and services. Additionally, funds from the financing will be used to enhance operating efficiency to further strengthen the company’s leadership position in the NGS industry.
  • M&A Terms
  • Venture Investor
    CMB Capital
  • Venture Investor
    Innovation and Investment Company
  • Venture Investor
    Sigma Group

Trending on Xconomy